Results 61 to 70 of about 30,227 (301)
Defining CYP3A4 Structural Responses to Substrate Binding. Raman Spectroscopic Studies of a Nanodisc-incorporated Mammalian Cytochrome P450 [PDF]
, 2011 Resonance Raman (RR) spectroscopy is used to help define active site structural responses of nanodisc-incorporated CYP3A4 to the binding of three substrates: bromocriptine (BC), erythromycin (ERY), and testosterone (TST).
Denisov, Ilia G. +4 more
core +3 more sources
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2015 In the article Gaziano et al, “Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects,” which published online October 12, 2012, and appeared in the October ...
L. Wilkins
semanticscholar +1 more source
Clinical Presentation and Management of Mastalgia: A Cohort Study [PDF]
Journal of Clinical and Diagnostic Research, 2020 Introduction: Recurring mastalgia, non-cyclical mastalgia and nonspecific extra-mammary pain are usually categorised as breast pain. Aim: To determine the most usual aetiology of mastalgia and its response to management modalities like topical Non ...
TG Raghu
doaj +1 more source
Study to assess the role of bromocriptine in treatment of diabetes mellitus [PDF]
, 2016 Background: Bromocriptine is a dopamine D2 receptor agonist and a sympatholytic agent used very frequently in treatment of hyperprolactinemia, Parkinsonism and acromegaly.
Dikshit, Harihar +3 more
core +2 more sources
Transdermal Administration of Bromocriptine.
Biological and Pharmaceutical Bulletin, 2003 Bromocriptine (BRC) has been mainly used for the inhibition of lactation, treatment of menstrual disorders, Parkinson disease, breast tumours, infertility and brain tumours as a dopamine agonist in clinics. But current BRC formulations have some side effects and bioavailability problems because of hepatic first pass effect.
Lortlar, ND +3 more
openaire +5 more sources
Cell Proliferation, EarlyView.Polymeric nanoparticles represent promising drug (gene) delivery carriers to the brain due to their unique advantages to facilitate the penetration of blood–brain barrier and endocytosis of neuronal cells in neurodegenerative diseases. ABSTRACT In spite of great advances in modern medicine, there are a few effective strategies for the treatment of ...
Lian Jin +4 more
wiley +1 more source
The pituitary TGFb1 system as a novel target for the treatment of resistant prolactinomas [PDF]
, 2016 Prolactinomas are the most frequently observed pituitary adenomas and most of themrespond well to conventional treatment with dopamine agonists (DAs).
Camilletti, María Andrea +3 more
core +2 more sources
Journal of Diabetes Research, 2015 Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk.
Citation Chamarthi +14 more
semanticscholar +1 more source
Equine Veterinary Journal, EarlyView.Abstract Background Due to the high frequency of laminitis reported for both conditions, the relationship between pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID), and the potential role of dopamine in modifying insulin secretion, requires further investigation.
Nicolas C. Galinelli +7 more
wiley +1 more source
A peripartum cardiomyopathy case treated with bromocriptine
Turkish Journal of Internal Medicine, 2021 Introduction: Peripartum cardiomyopathy is a rare disease that is difficult to diagnose and treat. Clinical findings are similar with heart failure. New treatments are needed in addition to the treatment of heart failure.
Dilek Yeşilbursa +4 more
doaj +1 more source